Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
Sign Up to like & getrecommendations! Published in 2022 at "Osteoporosis International"
DOI: 10.1007/s00198-021-06268-9
Abstract: This paper systematically reviewed and assessed all retrievable pharmacoeconomic studies on denosumab for the treatment of osteoporosis. Denosumab was more cost-effective in patients with older age, prior fracture experience, lower BMD T-scores, and more risk… read more here.
Keywords: pharmacoeconomic studies; denosumab osteoporosis; cost; osteoporosis ... See more keywords